Lupin receives EIR from U.S. FDA for its Dabhasa facility EP News Bureau Jul 15, 2024 The facility receives U.S. FDA 'No Action Indicated' status
Lupin appoints Abdelaziz Toumi as CEO of its API CDMO subsidiary EP News Bureau Jun 17, 2024 Holding a Doctorate in chemical engineering, Abdel, brings over two decades of experience in the biotech, pharma and CDMO sectors…